Company Filing History:
Years Active: 2005
Title: Yi Lin - Innovator in Transgenic Endothelial Cell Research
Introduction
Yi Lin is a prominent inventor based in Saint Paul, MN (US). She has made significant contributions to the field of biomedical engineering, particularly in the area of transgenic endothelial cells. Her innovative work has the potential to enhance the biocompatibility of medical devices and advance gene therapy techniques.
Latest Patents
Yi Lin holds a patent for a process that expands the population of endothelial cells obtained from peripheral blood. This process involves transforming these cells with a vector that contains a DNA sequence encoding a preselected bioactive polypeptide. The resulting transgenic endothelial cells are not only useful for biocompatibilizing implantable medical devices but can also be utilized directly in gene therapy applications. She has 1 patent to her name.
Career Highlights
Yi Lin is affiliated with the University of Minnesota, where she conducts her research and development. Her work has garnered attention for its innovative approach to solving complex medical challenges.
Collaborations
Some of her notable coworkers include Robert P. Hebbel and John S. Lollar, who have collaborated with her on various research projects.
Conclusion
Yi Lin's contributions to the field of transgenic endothelial cells exemplify her dedication to advancing medical technology. Her innovative research continues to pave the way for future developments in biocompatibility and gene therapy.